Yong‐Yao Cui

1.1k total citations
46 papers, 890 citations indexed

About

Yong‐Yao Cui is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yong‐Yao Cui has authored 46 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Physiology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yong‐Yao Cui's work include Neuroscience and Neuropharmacology Research (11 papers), Alzheimer's disease research and treatments (9 papers) and Asthma and respiratory diseases (9 papers). Yong‐Yao Cui is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Alzheimer's disease research and treatments (9 papers) and Asthma and respiratory diseases (9 papers). Yong‐Yao Cui collaborates with scholars based in China, France and Belgium. Yong‐Yao Cui's co-authors include Hongzhuan Chen, Liang Zhu, Hong Qi, Lina Hou, Wei Zhou, Yu Qiu, Liang Zhu, Hao Wang, Zhengxing Rong and Juan Li and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Yong‐Yao Cui

45 papers receiving 876 citations

Peers

Yong‐Yao Cui
Yong‐Yao Cui
Citations per year, relative to Yong‐Yao Cui Yong‐Yao Cui (= 1×) peers Valentina Latina

Countries citing papers authored by Yong‐Yao Cui

Since Specialization
Citations

This map shows the geographic impact of Yong‐Yao Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Yao Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Yao Cui more than expected).

Fields of papers citing papers by Yong‐Yao Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐Yao Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Yao Cui. The network helps show where Yong‐Yao Cui may publish in the future.

Co-authorship network of co-authors of Yong‐Yao Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐Yao Cui. A scholar is included among the top collaborators of Yong‐Yao Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐Yao Cui. Yong‐Yao Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Yun, et al.. (2016). The activation of M3 mAChR in airway epithelial cells promotes IL-8 and TGF-β1 secretion and airway smooth muscle cell migration. Respiratory Research. 17(1). 25–25. 11 indexed citations
2.
Song, Yun, et al.. (2016). A mucoactive drug carbocisteine ameliorates steroid resistance in rat COPD model. Pulmonary Pharmacology & Therapeutics. 39. 38–47. 12 indexed citations
3.
Gong, Ping, Yu Qiu, Wei Zhou, et al.. (2014). Subneurotoxic copper(II)-induced NF-κB-dependent microglial activation is associated with mitochondrial ROS. Toxicology and Applied Pharmacology. 276(2). 95–103. 66 indexed citations
4.
Song, Yun, Jianrong Xu, Xiaolin Wang, et al.. (2014). Carbocysteine restores steroid sensitivity by targeting histone deacetylase 2 in a thiol/GSH-dependent manner. Pharmacological Research. 91. 88–98. 21 indexed citations
5.
Yang, Kai, Yun Song, Wei Zhou, et al.. (2014). mAChRs activation induces epithelial-mesenchymal transition on lung epithelial cells. BMC Pulmonary Medicine. 14(1). 53–53. 24 indexed citations
6.
Song, Yun, Kai Yang, Wei Zhou, et al.. (2014). M3 mAChR-mediated IL-8 expression through PKC/NF-κB signaling pathways. Inflammation Research. 63(6). 463–473. 6 indexed citations
7.
Hou, Lina, Jianrong Xu, Qingnan Zhao, et al.. (2013). A New Motif in the N‐Terminal of Acetylcholinesterase Triggers Amyloid‐β Aggregation and Deposition. CNS Neuroscience & Therapeutics. 20(1). 59–66. 16 indexed citations
8.
Teng, Lin, Ya‐Bin Tang, Zhang Chun, et al.. (2013). Non-Neuronal Release of Gamma-Aminobutyric Acid by Embryonic Pluripotent Stem Cells. Stem Cells and Development. 22(22). 2944–2953. 11 indexed citations
9.
Tan, Panpan, Xu Zhu, Yong‐Yao Cui, et al.. (2013). Activation of Muscarinic Receptors Protects against Retinal Neurons Damage and Optic Nerve Degeneration In Vitro and In Vivo Models. CNS Neuroscience & Therapeutics. 20(3). 227–236. 26 indexed citations
10.
Yu, Zhihua, Jianrong Xu, Yanxia Wang, et al.. (2013). Targeted Inhibition of KCa3.1 Channel Attenuates Airway Inflammation and Remodeling in Allergic Asthma. American Journal of Respiratory Cell and Molecular Biology. 48(6). 685–693. 36 indexed citations
11.
Zheng, Wei, Juan Li, Zhuibai Qiu, et al.. (2012). Novel bis-(−)-nor-meptazinol derivatives act as dual binding site AChE inhibitors with metal-complexing property. Toxicology and Applied Pharmacology. 264(1). 65–72. 16 indexed citations
12.
Zheng, Jun, Xuemei Feng, Lina Hou, et al.. (2011). Latanoprost Promotes Neurite Outgrowth in Differentiated RGC-5 Cells via the PI3K-Akt-mTOR Signaling Pathway. Cellular and Molecular Neurobiology. 31(4). 597–604. 32 indexed citations
13.
Wang, Hao, Lina Hou, Zheng Xia, et al.. (2010). Modulatory effect of anisodamine on airway hyper-reactivity and eosinophilic inflammation in a murine model of allergic asthma. International Immunopharmacology. 11(2). 260–265. 20 indexed citations
14.
Zhang, Weiwei, Yong‐Yao Cui, Hao Wang, et al.. (2009). Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine. Journal of Neural Transmission. 116(12). 1643–1649. 2 indexed citations
15.
Xia, Zheng, Qiong Xie, Juan Li, et al.. (2009). Novel piperazine derivative PMS1339 exhibits tri-functional properties and cognitive improvement in mice. The International Journal of Neuropsychopharmacology. 12(10). 1409–1409. 17 indexed citations
16.
Zhu, Xu, Wei Zhou, Yong‐Yao Cui, et al.. (2009). Pilocarpine Protects Cobalt Chloride-induced Apoptosis of RGC-5 Cells: Involvement of Muscarinic Receptors and HIF-1α Pathway. Cellular and Molecular Neurobiology. 30(3). 427–435. 27 indexed citations
17.
Zhu, Liang, et al.. (2008). The absolute configuration plays an important role in muscarinic activity of BGT-A and its analogs. Bioorganic & Medicinal Chemistry. 16(24). 10251–10256. 7 indexed citations
18.
Li, Juan, Liang Zhu, Yong‐Yao Cui, et al.. (2007). PMS777, A Bis-interacting Ligand for PAF Receptor Antagonism and AChE Inhibition, Attenuates PAF-induced Neurocytotoxicity in SH-SY5Y Cells. Cellular and Molecular Neurobiology. 28(1). 125–136. 5 indexed citations
19.
Liu, Huizhong, Yong‐Yao Cui, Liang Zhu, et al.. (2005). Activity and QSAR study of baogongteng A and its derivatives as muscarinic agonists. Bioorganic & Medicinal Chemistry Letters. 15(21). 4814–4818. 15 indexed citations
20.
Zhu, Liang, et al.. (2005). Aceclidine and pilocarpine interact differently with muscarinic receptor in isolated rabbit iris muscle. Life Sciences. 78(14). 1617–1623. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026